Skip to main content

Radical Hysterectomy and Pelvic Lymphadenectomy

Radical hysterectomy with pelvic (and often paraaortic) lymphadenectomy is the primary surgical treatment for early-stage cervical cancer, and it carries a materially higher genitourinary complication burden than simple hysterectomy because the parametrial dissection that defines its radicality runs directly through the ureter's and bladder's vascular and nerve supply.[1][2] This page is not about the cancer operation itself. It describes where the dissection places the ureter and bladder at risk, how radicality and nerve preservation trade off against urinary morbidity, and the reconstructive urologist's role in prevention, recognition and repair.

See also: Hysterectomy for the non-radical operation, Intraoperative Urologic Consultation for the general injury-recognition and repair framework, The Cervix and Pelvic Neuroanatomy for the parametrial and autonomic anatomy, and Ureteral Trauma and Ureterovaginal Fistula for organ-specific repair.

Radicality and the Querleu-Morrow Classification​

Radical hysterectomy is classified by how far laterally the parametrial dissection extends, following the 2017 update to the Querleu-Morrow classification (types A through D, with C subdivided into C1 nerve-sparing and C2 non-nerve-sparing).[1] Greater radicality removes more parametrial and paracolpal tissue to achieve a wider surgical margin around the tumor, and it correspondingly divides more of the autonomic and vascular supply that the ureter and bladder share with that tissue. A randomized comparison of class II versus class III radical hysterectomy in stage IB-IIA cervical cancer found similar disease-free and overall survival between classes, with the more radical class III operation associated with more frequent bladder dysfunction and a longer time to spontaneous voiding.[3]

A 2024 multicenter noninferiority trial (CX.5/SHAPE, 700 patients with lesions ≤2 cm and limited stromal invasion) found simple hysterectomy noninferior to radical hysterectomy for 3-year pelvic recurrence in this selected low-risk population (2.17% vs. 2.52%), with significantly lower urinary incontinence (beyond 4 weeks: 4.7% vs. 11.0%, P = 0.003) and urinary retention (beyond 4 weeks: 0.6% vs. 9.9%, P < 0.001) after simple hysterectomy.[4] This result does not extend beyond the trial's low-risk eligibility criteria and does not substitute for oncologic guidance on patient selection; it demonstrates that urinary morbidity scales directly with radicality in a population where the extra margin did not improve cancer control.

Ureteral Injury​

Anatomy of Risk​

The ureter crosses the common iliac bifurcation, travels along the pelvic sidewall medial to the internal iliac artery, and passes through the parametrium beneath the uterine artery before entering the ureteric tunnel and the bladder. Radical hysterectomy specifically widens the parametrial dissection around this tunnel to obtain tumor clearance, and skeletonizing the ureter to achieve that clearance predictably compromises some of its segmental periureteral blood supply.[2] Operative teaching for this step emphasizes gentle, meticulous dissection, preservation of the adventitia, avoidance of thermal energy near the ureter, and careful field inspection at the completion of the parametrial dissection.[2] Some authors express concern that a ureteral stent can stiffen the ureter and increase the risk of shearing its feeder vessels during this dissection; this is attributed opinion, not a general contraindication to stenting.[2]

Incidence​

A 10-year English National Health Service cohort of 377,073 hysterectomies found ureteric injury rates after 2006 of 10.7% (95% CI 7.3-15.1%) for abdominal radical hysterectomy for uterine cancer, and 1.9-4.0% (depending on procedure) for ovarian and cervical cancer surgery — substantially higher than the typically sub-1% rates for benign hysterectomy in the same cohort.[5] A separate chapter-level synthesis of radical-hysterectomy-specific literature reports a narrower 1-2% range for immediate or delayed ureteral injury, without a single denominator or harmonized operative class across the pooled studies; these figures should be read as a general order of magnitude rather than a precise, comparable rate.[2]

Prevention Adjuncts for Lymphadenectomy​

During pelvic and paraaortic lymphadenectomy, the ureter is at risk along its course across the common iliac bifurcation and beside the pelvic vessels toward the ureteric tunnel; in a midline left paraaortic approach, the left ureter can be difficult to see behind the sigmoid mesentery.[6] The standard approach identifies and mobilizes both ureters before nodal dissection, keeps them out of the operative field, and uses noncrushing handling to preserve their segmental blood supply.[6] For unusually difficult exposure — for example, left paraaortic nodes in an obese patient, or grossly positive nodes — preprocedural ureteral stenting or intraureteral indocyanine green with near-infrared imaging has been described as an adjunct for identification.[6] This is selective operative guidance for difficult anatomy, not a demonstrated reduction in injury rate from a comparative trial; the chapter's cited background on ureteral-surgery trends at an academic gynecologic oncology service is a descriptive report, not a prevention study.[7]

Recognition​

Continual field awareness and direct ureteral inspection during and after the parametrial and nodal dissection are the primary recognition tools.[6] IV fluorescein or indigo carmine with cystoscopic assessment of ureteral efflux can help confirm a gross leak or absent orifice efflux; the general recognition toolkit (retrograde pyelography, methylene blue, sodium fluorescein) is on Intraoperative Urologic Consultation. Ureteral-injury management itself follows the organ-specific repair pathway on Ureteral Trauma; this page does not duplicate that workflow.

Bladder Injury​

Anatomy of Risk​

Radical hysterectomy requires wider bladder mobilization than simple hysterectomy to obtain adequate vaginal and parametrial margins, which increases risk near the trigone.[2] Cautious lateral bladder dissection, occasional intraoperative bladder backfilling to confirm the dissection plane in difficult cases, and judicious use of energy near the bladder wall are described operative practices.[2]

Incidence​

A chapter-level synthesis of the radical-hysterectomy literature reports bladder injury rates of up to 4%, again without a single harmonized denominator across the underlying studies.[2] As with ureteral injury, this should be read as an order-of-magnitude estimate drawn from heterogeneous older observational series rather than a precise contemporary rate.

Recognition​

Thermal bladder injury may present days to weeks after surgery rather than intraoperatively. Large-volume clear fluid from a drain or the vagina warrants assessment; described confirmation methods include creatinine testing of the fluid, dyed bladder backfill with inspection of the vaginal cuff for extravasation, and CT urogram for localization and assessment of any associated injury.[2] Bladder-injury repair follows the organ-specific pathway on Bladder Trauma.

Postoperative Bladder Dysfunction​

Radical hysterectomy, independent of a discrete intraoperative injury, is associated with voiding dysfunction from autonomic nerve injury during the parametrial dissection. Greater radicality is associated with more frequent and more persistent bladder dysfunction.[3][2] In a randomized comparison, class III (versus class II) radical hysterectomy was associated with a longer time to resumption of spontaneous voiding.[3]

Nerve-Sparing Modification​

Querleu-Morrow type C1 nerve-sparing radical hysterectomy aims to identify and preserve the hypogastric nerve, the inferior hypogastric plexus and the bladder branches while dividing the uterine branches, in contrast to the non-nerve-sparing C2 dissection.[1] In a prospective series of 117 patients who underwent type C1 nerve-sparing radical hysterectomy with pelvic lymphadenectomy without adjuvant radiotherapy, postvoid residual exceeded 100 mL in 4.7% (5/106) of patients available for follow-up at postoperative day 5, requiring temporary suprapubic catheterization; voiding without a postvoid residual was achieved in all patients within 14 days, and urodynamic parameters at 12 months did not differ significantly from preoperative values apart from a slight increase in maximum cystometric capacity.[8] A separate urodynamic study of type C3-C4 (class III-IV) nerve-sparing radical hysterectomy in 15 patients found reduced detrusor activity during voiding in 53% and overactive detrusor in 27% at a median of 4 months postoperatively, with no patient developing de novo incontinence and bladder compliance unchanged; the authors concluded that a mild degree of bladder impairment occurs even with hypogastric nerve preservation.[9] Nerve preservation can reduce, but does not eliminate, bladder dysfunction after radical hysterectomy. The extent of parametrial resection required for adequate oncologic clearance determines whether nerve-sparing can be performed; the technique itself does not override that requirement.[1]

Postoperative Catheter Management​

Described postoperative bladder-care practices include active voiding trials, scheduled voiding to avoid overdistention, and clean intermittent self-catheterization when spontaneous emptying remains impaired; catheter duration varies by practice and no fixed protocol is established across institutions.[2] One described bladder-care protocol in laparoscopic radical hysterectomy assessed earlier catheter removal; detailed voiding-trial criteria and outcome rates from that protocol are not reproduced here, as the chapter synthesis cites it only as one described approach rather than a comparative trial establishing superiority.[10]

Surgical Approach and Oncologic Outcome​

The choice between open and minimally invasive radical hysterectomy affects more than urinary morbidity, and belongs to the oncologic decision rather than this page's scope. The 2018 LACC trial (631 patients with early-stage cervical cancer) found minimally invasive radical hysterectomy associated with lower 3-year disease-free survival (91.2% vs. 97.1%; hazard ratio for recurrence or death 3.74, 95% CI 1.63-8.58) and lower overall survival (93.8% vs. 99.0%; hazard ratio for death 6.00, 95% CI 1.77-20.30) compared with open radical hysterectomy.[11] This finding reversed the prior assumption that minimally invasive and open radical hysterectomy were oncologically equivalent and should inform, but not substitute for, the reconstructive urologist's expectations about the approach a patient is likely to have had before referral.

See Also​

References​

1. Querleu D, Cibula D, Abu-Rustum NR. 2017 Update on the Querleu-Morrow Classification of Radical Hysterectomy. Ann Surg Oncol. 2017;24(11):3406-3412. doi:10.1245/s10434-017-6031-z

2. Hoffman M, Bou Zgheib N, Avila M, Chern JY. Radical Hysterectomy. In: Hoffman M, Hull TL, Bochner BH, eds. Major Complications of Female Pelvic Surgery: A Multidisciplinary Approach. Springer; 2025:363-370.

3. Landoni F, Maneo A, Cormio G, et al. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80(1):3-12. doi:10.1006/gyno.2000.6010

4. Plante M, Kwon JS, Ferguson S, et al. Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer. N Engl J Med. 2024;390(9):819-829. doi:10.1056/NEJMoa2308900

5. Kiran A, Hilton P, Cromwell DA. The risk of ureteric injury associated with hysterectomy: a 10-year retrospective cohort study. BJOG. 2016;123(7):1184-1191. doi:10.1111/1471-0528.13576

6. Hoffman M, Shames M, Bochner BH. Pelvic and Paraaortic Lymphadenectomy. In: Hoffman M, Hull TL, Bochner BH, eds. Major Complications of Female Pelvic Surgery: A Multidisciplinary Approach. Springer; 2025:357-358.

7. Martin A, Wells A, Anderson ML, et al. Trends in ureteral surgery on an academic gynecologic oncology service. Gynecol Oncol. 2021;163(3):552-556. doi:10.1016/j.ygyno.2021.10.009

8. Novackova M, Pastor Z, Chmel R Jr, Brtnicky T, Chmel R. Urinary tract morbidity after nerve-sparing radical hysterectomy in women with cervical cancer. Int Urogynecol J. 2020;31(5):981-987. doi:10.1007/s00192-019-04083-9

9. Maneschi F, Ianiri P, Sarno M, Gagliardi F, Panici PB. Nerve-sparing class III-IV radical hysterectomy: urodynamic study and surgical technique. Int J Gynecol Cancer. 2012;22(4):675-680. doi:10.1097/IGC.0b013e3182473256

10. Campbell P, Casement M, Addley S, et al. Early catheter removal following laparoscopic radical hysterectomy for cervical cancer: assessment of a new bladder care protocol. J Obstet Gynaecol. 2017;37(7):970-972. doi:10.1080/01443615.2017.1328668

11. Ramirez PT, Frumovitz M, Pareja R, et al. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. N Engl J Med. 2018;379(20):1895-1904. doi:10.1056/NEJMoa1806395